by GlaxoSmithKline
ZIAGEN TABLETS is supplied by GlaxoSmithKline under product code ZIAGEN TABLETS 300 MG, ZIAGEN COMPRESSE, ZIAGEN COMPRIMES PELLICULES, ZIAGEN COMPRIMIDOS RECUBIERTOS, ZIAGEN COMPRIMIDOS REVESTIDOS, ZIAGEN APVALKOTAS TABLETES, ZIAGEN FILMOMHULDE TABLETTEN, ZIAGEN POTAHOVANE TABLETY, ZIAGEN TABLETAS, ZIAGEN TABLETE, ZIAGEN TABLETTEN, ZIAGEN TABLETTER, ZIAGEN TABLETY, ZIAGENAVIR TABLETS, A BACAVIR HEMISULPHATE, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.
This SDS was last revised on 24 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.
Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.
Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.
Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.
2026 © Copyright International Safety Data Sheet Service™
To continue, please log in or Register for your free account
To continue, please log in or Register for your free account
To reset your password, please enter your email address or username below.
Please log in to download the Risk Assessment.